Millipore Corporation has appointed Dr Martin D Madaus as president and CEO of Millipore, with effective no later than February 1, 2005. Dr Madaus comes to Millipore from Roche Diagnostics Corporation where he led a $1.9-billion business with 4,000 employees.

Francis J Lunger, who will remain as chairman of the Board during a transition period, will be replaced by Dr Madaus. He will also join with Millipore's Board of Directors.

Dr Madaus commented, "I'm very excited about joining a company with the reputation and potential of Millipore. The company's products and technologies are critical to the future of biotechnology and life science research."

Dr Robert Bishop, the lead director on Millipore's Board of Directors, said, "Dr Madaus has exceptional technical, business and international experience, and the energy and vision to lead Millipore through its next stage of growth."

Dr Madaus was appointed as president and CEO of Roche Diagnostics Corporation in the United States in 2000. Prior to that, he served as vice-president of Business Development for Roche Molecular Diagnostics. He came to Roche in 1998 when he was the general manager of Boehringer Mannheim Canada in Montreal, Quebec, through the acquisition of Boehringer Mannheim by Roche. From 1989 to 1998, Dr Madaus worked at Boehringer Mannheim in senior management, sales and marketing and product management roles both in Germany and the United States.